“ú–{ˆã‰È‘åŠwˆãŠw‰ïŽGŽ Online Journal ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚ð”ò‚΂·
‘–ÚŽŸ > †–ÚŽŸ > Abstract ƒz[ƒ€‚Ö–ß‚é
Abstract

‘æ3Šª 2007”N6ŒŽ@‘æ3†

‘S•¶PDF (627K)

¡Ç—á•ñ

tŒ™F‘f×–EŠà‚É‘Sg«ALƒAƒ~ƒƒCƒh[ƒVƒX‚ð‡•¹‚µ‚½1—á
’†‘º@‘s1, ŒÜ\—’@–L1, •l“c@˜a“T1, “c‘º@_ˆê2,5, ™è@—Sˆê2, –Ø‘º@„3, “¡“c@Œb”üŽq4, •Ÿ“c@—I4
1“ú–{ˆã‰È‘åŠwˆãŠw•”6”N
2“ú–{ˆã‰È‘åŠw•t‘®•a‰@•a—•”
3“ú–{ˆã‰È‘åŠw”å”AŠí‰ÈŠw
4“ú–{ˆã‰È‘åŠw‰ðÍl‘Ì•a—Šw
5“Œ‹ž’üM•a‰@•a—‰È

A Case of Renal Chromophobe Cell Carcinoma with Systemic AL Amyloidosis
Shoko Nakamura1, Yutaka Igarashi1, Kazunori Hamada1, Koichi Tamura2,5, Yuichi Sugisaki2, Gou Kimura3, Yumiko Fujita4 and Yuh Fukuda4
16th Grade of Medical Student, Nippon Medical School
2Division of Surgical Pathology, Nippon Medical School Hospital
3Department of Urology, Nippon Medical School
4Department of Analytic Human Pathology, Nippon Medical School
5Division of Pathology, Tokyo Teishin Hospital

Patients with malignant tumors are four times more likely to experience systemic amyloidosis, especially AA amyloidosis, and a quarter of these malignant tumors are renal clear cell carcinomas. However, reports of malignancies with AL amyloidosis are extremely rare. We report on a 66-year-old female with AL systemic amyloidosis and renal chromophobe cell carcinoma. We also survey the mechanism of the association by reviewing previous case reports.

“úˆã‘åˆã‰ïŽ 2007; 3(3), 141-146

Key words
renal chromophobe cell carcinoma, AL amyloidosis, cardiac amyloidosis, pathology

Correspondence to
Yuh Fukuda, Department of Analytic Human Pathology, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, 113-8602, Japan
E-mailFfukuda@nms.ac.jp

Žó•tF2007”N4ŒŽ12“ú@Žó—F2007”N5ŒŽ31“ú

ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚Ö–ß‚é ‚±‚̃y[ƒW‚̃gƒbƒv‚Ö–ß‚é